- Home
- STEW vs GRAL Comparison
STEW vs GRAL Comparison
Compare STEW & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEW
- GRAL
- Stock Information
- Founded
- STEW 1972
- GRAL 2016
- Country
- STEW United States
- GRAL United States
- Employees
- STEW N/A
- GRAL N/A
- Industry
- STEW Investment Managers
- GRAL
- Sector
- STEW Finance
- GRAL
- Exchange
- STEW Nasdaq
- GRAL NYSE
- Market Cap
- STEW 1.6B
- GRAL 1.3B
- IPO Year
- STEW N/A
- GRAL N/A
- Fundamental
- Price
- STEW $17.86
- GRAL $49.23
- Analyst Decision
- STEW
- GRAL Buy
- Analyst Count
- STEW 0
- GRAL 3
- Target Price
- STEW N/A
- GRAL $31.50
- AVG Volume (30 Days)
- STEW 84.5K
- GRAL 1.5M
- Earning Date
- STEW 01-01-0001
- GRAL 08-12-2025
- Dividend Yield
- STEW 3.71%
- GRAL N/A
- EPS Growth
- STEW N/A
- GRAL N/A
- EPS
- STEW 1.44
- GRAL N/A
- Revenue
- STEW N/A
- GRAL $130,711,000.00
- Revenue This Year
- STEW N/A
- GRAL $19.52
- Revenue Next Year
- STEW N/A
- GRAL $20.37
- P/E Ratio
- STEW $10.34
- GRAL N/A
- Revenue Growth
- STEW N/A
- GRAL 30.47
- 52 Week Low
- STEW $11.97
- GRAL $12.33
- 52 Week High
- STEW $14.94
- GRAL $63.99
- Technical
- Relative Strength Index (RSI)
- STEW 63.21
- GRAL N/A
- Support Level
- STEW $17.45
- GRAL N/A
- Resistance Level
- STEW $17.40
- GRAL N/A
- Average True Range (ATR)
- STEW 0.17
- GRAL 0.00
- MACD
- STEW 0.05
- GRAL 0.00
- Stochastic Oscillator
- STEW 98.11
- GRAL 0.00
About STEW SRH Total Return Fund Inc.
SRH Total Return Fund, Inc. is a non-diversified closed-end management investment company. The company's investment objective is to seek total returns. Its fund utilizes a bottom-up, value-driven investment process to identify securities of good quality businesses trading below estimated intrinsic value. The Funds are available as an actively-managed closed-end fund, an actively managed ETF and a passively-managed ETF.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.